Related Experiment Videos
Immune status during albendazole therapy for hydatidosis
R M Matossian1, G N Awar, H Radwan
1Department of Microbiology, American University of Beirut, Lebanon.
Annals of Tropical Medicine and Parasitology
|February 1, 1992
Summary
Immunological monitoring helps tailor cystic hydatid treatment by tracking patient responses. Albendazole therapy effectiveness can be assessed through antibody and immune complex level variations.
Area of Science:
- Immunology
- Parasitology
- Pharmacology
Background:
- Cystic hydatid disease requires effective medico-surgical management.
- Monitoring host immune responses can optimize therapeutic strategies.
Observation:
- Immunological markers were assessed in patients during and after albendazole therapy.
- Variations in haemagglutination antibodies, specific IgG and IgM immunoglobulins, and circulating immune complexes were analyzed.
Findings:
- Individual host responses to cystic hydatid treatment can be assessed through immunological monitoring.
- Albendazole therapy induces measurable changes in specific antibody and immune complex levels.
Implications:
- Immunological monitoring allows for personalized guidance of cystic hydatid treatment.
- Understanding immune variations can lead to improved patient outcomes and therapeutic adjustments.